Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026)
Aquestive Therapeutics (AQST) posted Interest & Investment Income of $882000.0 for Q2 2026, up 962.65% on a QoQ basis from $83000.0 in Q1 2026, and down 57.92% year-over-year from $2.1 million in Q2 2025.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026) Analysis & Trends
Aquestive Therapeutics has reported Interest & Investment Income for 9 years, with the latest figure at $882000.0 in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 57.92% year-over-year to $882000.0 in Q2 2026; TTM through Jun 2026 was $2.5 million, a 44.21% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, up 27.06% from the prior year.
- Interest & Investment Income was $882000.0 for Q2 2026 at Aquestive Therapeutics, up from $83000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $14.5 million in Q1 2023, with the low at -$3000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $1.4 million, with a median of $521000.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income soared 483866.67% in 2023, then plunged 97.73% in 2024.
- Over 5 years, Interest & Investment Income stood at $65000.0 in 2022, then soared by 153.85% to $165000.0 in 2023, then soared by 344.85% to $734000.0 in 2024, then jumped by 70.57% to $1.3 million in 2025, then fell by 29.55% to $882000.0 in 2026.
- The last three Interest & Investment Income figures came in at $882000.0 (Q2 2026), $83000.0 (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Aquestive Therapeutics | 636.85 Mn | 538.36 Mn | 9.80 Mn | 882,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 882,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 306,000.00 |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 713,000.00 |
| Dec 31, 2024 | 734,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 129,000.00 |
| Mar 31, 2023 | 14.51 Mn |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | -33,000.00 |